Repligen
RGEN
#2589
Rank
โ‚น600.77 B
Marketcap
โ‚น10,665
Share price
-3.17%
Change (1 day)
-11.35%
Change (1 year)
Categories

Market capitalization of Repligen (RGEN)

Market cap: โ‚น600.77 Billion

As of March 2026 Repligen has a market cap of โ‚น600.77 Billion. This makes Repligen the world's 2589th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Repligen from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น600.77 B-28.47%
2025โ‚น839.89 B20.07%
2024โ‚น699.51 B-16.3%
2023โ‚น835.70 B7.43%
2022โ‚น777.91 B-28.62%
2021โ‚น1.089 T42.12%
2020โ‚น766.84 B123.23%
2019โ‚น343.52 B112.11%
2018โ‚น161.95 B60.48%
2017โ‚น100.91 B42.43%
2016โ‚น70.85 B14.39%
2015โ‚น61.94 B50.62%
2014โ‚น41.12 B52.87%
2013โ‚น26.90 B150.81%
2012โ‚น10.72 B90.25%
2011โ‚น5.63 B-12.86%
2010โ‚น6.47 B10.29%
2009โ‚น5.86 B3.54%
2008โ‚น5.66 B-29.03%
2007โ‚น7.98 B111.1%
2006โ‚น3.78 B-30.23%
2005โ‚น5.42 B44.5%
2004โ‚น3.75 B-37.03%
2003โ‚น5.95 B49.46%
2002โ‚น3.98 B27.27%
2001โ‚น3.13 B-25.22%
2000โ‚น4.18 B38.09%
1999โ‚น3.03 B209.27%
1998โ‚น0.98 B77.46%
1997โ‚น0.55 B-18.65%
1996โ‚น0.67 B

End of Day market cap according to different sources

On Mar 20th, 2026 the market cap of Repligen was reported to be:

โ‚น600.77 Billion
by Nasdaq info icon info icon
โ‚น600.77 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚น14.367 T 2,291.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น16.504 T 2,647.14%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น28.330 T 4,615.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น10.962 T 1,724.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น11.54 B-98.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น146.79 B-75.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น1.200 T 99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น754.29 B 25.55%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น974.96 B 62.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
โ‚น708.13 B 17.87%๐Ÿ‡บ๐Ÿ‡ธ USA